These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21826477)

  • 21. The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments.
    Kam PC; Nethery CM
    Anaesthesia; 2003 Jan; 58(1):28-35. PubMed ID: 12492666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-drug interaction between clopidogrel and the proton pump inhibitors.
    Norgard NB; Mathews KD; Wall GC
    Ann Pharmacother; 2009 Jul; 43(7):1266-74. PubMed ID: 19470853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clopidogrel and proton pump inhibitors: insufficient evidence of interaction].
    Hunfeld NG; Valkhoff VE; Touw DJ; Sturkenboom MC; Kuipers EJ
    Ned Tijdschr Geneeskd; 2011; 155(28):A2404. PubMed ID: 21771376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton pump inhibitor and clopidogrel interaction: fact or fiction?
    Laine L; Hennekens C
    Am J Gastroenterol; 2010 Jan; 105(1):34-41. PubMed ID: 19904241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart disease.
    Vinholt P; Poulsen TS; Korsholm L; Kristensen SR; Hallas J; Damkier P; Mickley H
    Thromb Haemost; 2005 Aug; 94(2):438-43. PubMed ID: 16113837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between clopidogrel and proton pump inhibitors: hypothesis to explain multifactorial CYP2C19 inhibition.
    Zhang H; Ragueneau-Majlessi I; Levy RH
    Drug Metab Lett; 2009 Dec; 3(4):287-9. PubMed ID: 19995331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clopidogrel--proton pump inhibitors drug interaction: implications to clinical practice].
    Fontes-Carvalho R; Albuquerque A
    Rev Port Cardiol; 2010 Oct; 29(10):1555-67. PubMed ID: 21268429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of clopidogrel and statins in secondary prevention after cerebral ischaemia - a randomized, double-blind, double-dummy crossover study.
    Siepmann T; Heinke D; Kepplinger J; Barlinn K; Gehrisch S; Grählert X; Schwanebeck U; Reichmann H; Puetz V; Bodechtel U; Gahn G
    Br J Clin Pharmacol; 2014 Nov; 78(5):1058-66. PubMed ID: 24803100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.
    Savi P; Herbert JM
    Semin Thromb Hemost; 2005 Apr; 31(2):174-83. PubMed ID: 15852221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYP-mediated pharmacologic interference with optimal platelet inhibition.
    Cuisset T; Quilici J
    J Cardiovasc Transl Res; 2013 Jun; 6(3):404-10. PubMed ID: 23314910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinically relevant interaction between clopidogrel and proton pump inhibitors].
    Alban S; Dingermann T; Griese N; Kämmerer W; Schubert-Zsilavecz M; Schulz M; Trenk D; Zagermann-Muncke P
    Pharm Unserer Zeit; 2009; 38(4):370-1. PubMed ID: 19572357
    [No Abstract]   [Full Text] [Related]  

  • 32. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV; Papathanasiou AI; Rodis FI; Elisaf M; Goudevenos JA; Tselepis AD
    Circulation; 2004 Mar; 109(11):1335-8. PubMed ID: 15023882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical relevance of the clopidogrel-proton pump inhibitor interaction.
    Mohammad A; Brilakis ES; Weideman RA; Little BB; Banerjee S
    J Cardiovasc Transl Res; 2012 Aug; 5(4):547-52. PubMed ID: 22351048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of clopidogrel on the steady-state pharmacokinetics of fluvastatin.
    Ayalasomayajula SP; Vaidyanathan S; Kemp C; Prasad P; Balch A; Dole WP
    J Clin Pharmacol; 2007 May; 47(5):613-9. PubMed ID: 17442686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between statins and clopidogrel: is there anything clinically relevant?
    Bhindi R; Ormerod O; Newton J; Banning AP; Testa L
    QJM; 2008 Dec; 101(12):915-25. PubMed ID: 18676683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of human cytochrome P450 inhibition by the thienopyridines prasugrel, clopidogrel, and ticlopidine.
    Hagihara K; Nishiya Y; Kurihara A; Kazui M; Farid NA; Ikeda T
    Drug Metab Pharmacokinet; 2008; 23(6):412-20. PubMed ID: 19122335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans.
    Farid NA; Kurihara A; Wrighton SA
    J Clin Pharmacol; 2010 Feb; 50(2):126-42. PubMed ID: 19948947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clopidogrel and proton pump inhibitors--boon or bane?].
    Labenz J; Meyners W; Petersen KU
    Dtsch Med Wochenschr; 2010 Feb; 135(5):203-6. PubMed ID: 20104441
    [No Abstract]   [Full Text] [Related]  

  • 39. The interaction between proton pump inhibitors and clopidogrel and upper gastrointestinal bleeding.
    Leontiadis GI; Yuan Y; Howden CW
    Gastrointest Endosc Clin N Am; 2011 Oct; 21(4):637-56. PubMed ID: 21944415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of rabeprazole on the antiplatelet effects and pharmacokinetics of clopidogrel in healthy volunteers.
    Funck-Brentano C; Szymezak J; Steichen O; Ducint D; Molimard M; Remones V; Azizi M; Gaussem P
    Arch Cardiovasc Dis; 2013 Dec; 106(12):661-71. PubMed ID: 24246616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.